EPISODE · Sep 17, 2023 · 40 MIN
Andrew Bascand: Investing in new technology
from The Weekend Collective · host Newstalk ZB
Andrew Bascand, Managing Director of Harbour Asset Management joins me to discuss new findings of the GLP-1 drug class, which has predominantly been used to treat type 2 diabetes but has captured notable mindshare with healthcare specialists and macro investors. Listen in for your chance to get ahead of the markets. LISTEN ABOVESee omnystudio.com/listener for privacy information.
NOW PLAYING
Andrew Bascand: Investing in new technology
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m